Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Aventurine Dial Watch Market Growth Accelerates As Industry Expected To Reach $1.9 Billion By 2030
EIN Presswire
The Business Research Company's Aventurine Dial Watch Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, May 25, 2026 /EINPresswire.com/ -- "The market for aventurine dial watches has...
Tourism Source Market Set to Reach USD 1.1 Trillion by 2032, With a Sustainable CAGR Of 6.6%
EIN Presswire
By booking channels, the mobile application segment is likely to remain dominant during the forecast period.
Oculis to Participate in Upcoming Investor Conferences
GlobeNewswire, Inc.
ZUG, Switzerland, April 07, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with...
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
GlobeNewswire, Inc.
REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and...
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
GlobeNewswire, Inc.
The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio® in healthy adult participants, met all its primary endpoints REYKJAVIK, Iceland, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alvotech...
European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union
GlobeNewswire, Inc.
Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency, in adult and pediatric patients aged 12 years and older First European...
Luxury Dome Car Tours Market Expanding With $1.99 Billion at 10.1% CAGR by 2030
EIN Presswire
The Business Research Company's Luxury Dome Car Tours Market Expanding With $1.99 Billion at 10.1% CAGR by 2030 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2026 /EINPresswire.com/ -- "The luxury dome car tours industry has witnessed notable...
Nanoq drilling results confirm significant gold copper mineralisation
GlobeNewswire, Inc.
Reykjavík, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Amaroq Ltd. (“Amaroq” or the “Company”) Nanoq drilling results confirm significant gold copper mineralisation **Consistent grade within multiple stacked zones and identification of identical, parallel...
Kitchen Joy brings authentic Asian recipes to European consumers
GlobeNewswire, Inc.
BANGKOK, March 31, 2026 (GLOBE NEWSWIRE) -- Kitchen Joy, a ready meal brand from CPF, is growing its presence in Europe with a broader range of Asian-inspired dishes, appetizers and cooked rice products, for modern consumers.
Bibliophiles Invited to Explore BookFest Award-Winning Books at the LA Times Festival of Books in Booth 153, Gold Zone
EIN Presswire
Black Château and Books That Make You showcase award-winning, bestselling, and debut titles April 18 and 19, 2026. LOS ANGELES, CA, UNITED STATES, March 25, 2026 /EINPresswire.com/ -- Booklovers are invited to discover their new favorite books...
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
GlobeNewswire, Inc.
PRIME designation follows recent Breakthrough Therapy designation from the U.S. FDA, underscoring the importance and urgency of addressing optic neuritis, a serious condition that can have negative long-term visual outcomes, significantly...
Casa Noosh x Amarna Gallery Present: The Gilded Affair at The Moore Club
EIN Presswire
A Night of Art, Luxury, and Curated Indulgence During Art Basel Miami 2025 MIAMI, FL, UNITED STATES, December 2, 2025 /EINPresswire.com/ -- This Art Basel, the city’s most influential tastemakers, collectors, celebrities, and cultural leaders...
Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights
GlobeNewswire, Inc.
Presented new data on CLD-401 at the AACR conference in San Diego, CA, detailing the profound immune changes in the tumor microenvironment induced by CLD-401; IND filing for CLD-401 expected by end of 2026 Presented new data on RedTail at the AACR...
Halli Thorleifsson Relaunches Ueno to Humanize the Future of Tech
EIN Presswire
REYKJAVíK, ICELAND, September 8, 2025 /EINPresswire.com/ -- Halli Thorleifsson, the celebrated designer and entrepreneur behind some of the most emotionally resonant digital experiences of the last decade, is relaunching his award-winning...
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
GlobeNewswire, Inc.
— The lowered pricing structure is now available for 16.984 ISK per bottle at pharmacies throughout Iceland AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the development...
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area
GlobeNewswire, Inc.
REYKJAVIK, Iceland, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Commission...
Q3 2025 Financial Results
GlobeNewswire, Inc.
Reykjavík, Nov. 14, 2025 (GLOBE NEWSWIRE) -- ("Amaroq" or the "Company") Q3 2025 Financial Results Growing revenues and restart of operations TORONTO, ONTARIO – 14 November 2025 – Amaroq Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ, OTCQX: AMRQF), an...
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
GlobeNewswire, Inc.
REYKJAVIK, Iceland and LONDON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited...
Critical Resource Race: The Multi-Billion Dollar Move Toward Secure Supply Chains
GlobeNewswire, Inc.
VANCOUVER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary — The U.S. just put over $30 billion on the table to shore up critical supply chains across 54 partner nations.
Nordic MSPs Can Now Access Heimdal's Unified Security and Compliance Platform Through Elovade
EIN Presswire
COPENHAGEN, DENMARK, March 19, 2026 /EINPresswire.com/ -- Heimdal has appointed Elovade as its official distributor in the Nordic region.
Sign up for:
Iceland Entertainment Insider
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.